Effect of prostaglandin E2 on eicosanoid release by human bronchial biopsy specimens from normal and inflamed mucosa

Thorax

Volumn 51, Issue 9, 1996, Pages 919-923

  Schafer D ^a   Lindenthal, U ^a   Wagner, M ^b   Bolcskei P L ^b   Baenkler, H W ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b Nuremberg Hospital   (Germany)

Author keywords

Eicosanoid metabolism; Human mucosa; Prostaglandin E2

Indexed keywords

ICOSANOID; PEPTIDOLEUKOTRIENE; PROSTAGLANDIN E2; THROMBOXANE B2; ACETYLSALICYLIC ACID; ARACHIDONIC ACID DERIVATIVE; CAFFEIC ACID DERIVATIVE; LEUKOTRIENE; THROMBOXANE A2;

ARTICLE; BRONCHUS BIOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN TISSUE; IN VITRO STUDY; PNEUMONIA; PRIORITY JOURNAL; ADULT; AGED; BIOPSY; BRONCHITIS; BRONCHUS; METABOLISM; MIDDLE AGED;

ADULT; AGED; ARACHIDONIC ACIDS; ASPIRIN; BIOPSY; BRONCHI; BRONCHITIS; CAFFEIC ACIDS; DINOPROSTONE; EICOSANOIDS; HUMANS; LEUKOTRIENES; MIDDLE AGED; THROMBOXANE A2;

EID: 0029658855     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.51.9.919     Document Type: Article

References (36)

1. Jeffery PK. Morphologic features of airway surface epithelial cells and glands. Am Rev Respir Dis 1983;128:14-20.
2. Ollerenshaw SL, Woolcock AJ. Characteristics of the inflammation in biopsies from large airways of subjects with asthma and subjects with chronic airflow limitation. Am Rev Respir Dis 1992;145:922-7.
3. Laitinen LA, Laitinen A, Haahtela T. Airway mucosal inflammation even in patients with newly diagnosed asthma. Am Rev Respir Dis 1993;147:697-704.
4. Kelley J. Cytokines of the lung. Am Rev Respir Dis 1990;141:765-88.
5. 2) by human bronchial epithelial cells. Am J Respir Cell Mol Biol 1989;1:245-50.
6. Dahlén SE, Björck T, Kumlin M, Granström E, Hedquist P. Studies of leukotrienes as mediators in the human lung in vitro. Adv Prostaglandin Thromboxane Leukotriene Res 1990;20:193-200.
7. Samuelsson B. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science 1983; 220:568-75.
8. Hamberg M, Svensson J, Samuelsson B. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci USA 1975;72:2994-8.
9. Lewis RA, Austen KF, Soberman RJ. Leukotrienes and other products of the 5-lipoxygenase pathway. N Engl J Med 1990;323:645-55.
10. Cohn LA, Adler KB. Interactions between airway epithelium and mediators of inflammation. Exp Lung Res 1992;18:299-322.
11. Herd CM, Page CP. Pulmonary immune cells in health and disease: platelets. Eur Respir J 1994;7:1145-60.
12. Holtzman MJ, Hausbrough JR, Rosen GD, Turk J. Uptake, release, and novel species-dependent oxygenation of arachidonic acid in human and animal airway epithelial cells. Biochim Biophys Acta 1988;963:401-13.
13. Abraham WM. The interaction among granulocyte lipid mediators and the generation of oxygene radicals in antigen-induced airway hyperresponsivness. Adv Prostaglandin Thromboxane Leukotriene Res 1994;22:133-53.
14. Weiß JW, Drazen JM, Coles M, McFadden ER, Weller P, Corey EJ, et al. Bronchoconstrictor effects of leukotriene C in humans. Science 1982;216:196-8.
15. 2: effect on airway and vascular smooth muscle. Prostaglandins 1977; 17: 425-36.
16. 4 increase the release of mucus from human airways in vitro. Am Rev Respir Dis 1982;126:449-51.
17. 2. Lancet 1995;345:436.
18. 4. Biochim Biophys Acta 1991;1081:274-8.
19. 2 antibody. FEBS Lett 1988;232:46-50.
20. Brune K, Reinke M, Lanz R, Peskar BA. Monoclonal antibodies against E- and F-type prostaglandins. FEBS Lett 1985;186:46-50.
21. Dray F, Mamas S, Bizzini B. Problems of PGE antisera specificity. Methods Enzymol 1982;86:258-69.
22. Bobrow MN, Harris TD, Shaughnessy KJ, Litt GJ. Catalyzed reporter deposition, a novel method of signal amplification. J Immunol Methods 1989;125:279-85.
23. Koshihara Y, Neichi T, Murota S, Lao A, Fujimoto T, Tatsuno T. Caffeic acid is a selective inhibitor for leukotriene biosynthesis. Biochim Biophys Acta 1984;792:92-7.
24. 2-terminal serine of prostaglandin synthase by aspirin. J Biol Chem 1978; 253:3782-4.
25. 4 production between eosinophils and neutrophils. J Allergy Clin Immunol 1989;83:393-400.
26. Marcus AJ. Eicosanoids: transcellular metabolism. In: Gallin JI, Goldstein IM, Snyderman R, eds. Inflammation: Basic principles and clinical correlates. New York: Raven Press, 1988:129-37.
27. 2 on excitatory neuro-effector transmission in the human bronchus. Prostaglandins 1990;39:639-55.
28. 4 release from activated neutrophils. Proc Natl Acad Sci USA 1983;80:4349-53.
29. 4. Br J Pharmacol 1992;107:226-32.
30. 2 on airway conductance in healthy subjects and asthmatic patients. Am Rev Respir Dis 1975;111:421-30.
31. O'Byrne PM, Jones GL. The effect of indomethacin on exercise-induced bronchoconstriction and refractoriness after exercise. Am Rev Respir Dis 1986;134:69-72.
32. Manning PJ, Lane CG, O'Byrne PM. The effect of oral prostaglandin E1 on airway responsiveness in asthmatic subjects. Pulmon Pharmacol 1989;2:121-4.
33. Kurosava M, Yodonowa S, Tsakagoshi H. Inhibition of bronchial hyperresponsiveness to histamine induced by intravenous administration of leukotriene C4 by novel thromboxane A2 receptor antagonists ONO-NT-126 and ONO-8809 in guinea pigs. Clin Exp Allergy 1993;23:843-50.
34. Larsen JS, Accosta EP. Leukotriene-receptor antagonists and 5-lipoxygenase inhibitors in asthma. Ann Pharmacother 1993;27:898-903.
35. 2 and aspirin-induced asthma. Lancet 1995;345:1056.
36. Lewis RA. Interaction of eicosanoids and cytokines in immune regulation. Adv Prostaglandin Thromboxane Leukotriene Res 1990;20:170-8.